Invests in publicly listed European healthcare companies active in specialty pharmaceuticals, medical technology, diagnostics, life science tools, specialized healthcare services, and selected healthcare platform companies. These businesses are characterized by clear strategic focus, strong positions in selected niches, scalable business models, disciplined capital allocation, and capital-efficient reinvestment that support high-quality growth.
Updated 2026-07-03